Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

Population Pharmacokinetics and Optimal Sampling Strategy for Model-Based Precision Dosing of Melphalan in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Mizuno K, Dong M, Fukuda T, Chandra S, Mehta PA, McConnell S, Anaissie EJ, Vinks AA.

Clin Pharmacokinet. 2018 May;57(5):625-636. doi: 10.1007/s40262-017-0581-x.

PMID:
28918602
2.

GWAS of 972 autologous stem cell recipients with multiple myeloma identifies 11 genetic variants associated with chemotherapy-induced oral mucositis.

Coleman EA, Lee JY, Erickson SW, Goodwin JA, Sanathkumar N, Raj VR, Zhou D, McKelvey KD, Apewokin S, Stephens O, Enderlin CA, Vangsted AJ, Reed PJ, Anaissie EJ.

Support Care Cancer. 2015 Mar;23(3):841-9. doi: 10.1007/s00520-014-2406-x. Epub 2014 Sep 14.

3.

Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET).

Kauffman CA, Freifeld AG, Andes DR, Baddley JW, Herwaldt L, Walker RC, Alexander BD, Anaissie EJ, Benedict K, Ito JI, Knapp KM, Lyon GM, Marr KA, Morrison VA, Park BJ, Patterson TF, Schuster MG, Chiller TM, Pappas PG.

Transpl Infect Dis. 2014 Apr;16(2):213-24. doi: 10.1111/tid.12186. Epub 2014 Mar 4.

4.

Atypical B12 deficiency with nonresolving paraesthesia.

Haider S, Ahmad N, Anaissie EJ, Abdel Karim N.

Case Rep Oncol Med. 2013;2013:823842. doi: 10.1155/2013/823842. Epub 2013 Nov 18.

5.

Comparison of an assumption-free Bayesian approach with Optimal Sampling Schedule to a maximum a posteriori Approach for Personalizing Cyclophosphamide Dosing.

Laínez JM, Orcun S, Pekny JF, Reklaitis GV, Suvannasankha A, Fausel C, Anaissie EJ, Blau GE.

Pharmacotherapy. 2014;34(4):330-5. doi: 10.1002/phar.1346. Epub 2013 Aug 27.

PMID:
24038448
6.

Risk factors, preemptive therapy, and antiperistaltic agents for Clostridium difficile infection in cancer patients.

Krishna SG, Zhao W, Apewokin SK, Krishna K, Chepyala P, Anaissie EJ.

Transpl Infect Dis. 2013 Oct;15(5):493-501. doi: 10.1111/tid.12112. Epub 2013 Aug 27.

PMID:
24034141
7.

Validation of a novel approach for dose individualization in pharmacotherapy using gabapentin in a proof of principles study.

Blau GE, Orcun S, Laínez JM, Reklaitis GV, Suvannasankha A, Fausel C, Anaissie EJ.

Pharmacotherapy. 2013 Jul;33(7):727-35. doi: 10.1002/phar.1267. Epub 2013 Apr 3.

PMID:
23553679
8.

Effects of exercise on fatigue, sleep, and performance: a randomized trial.

Coleman EA, Goodwin JA, Kennedy R, Coon SK, Richards K, Enderlin C, Stewart CB, McNatt P, Lockhart K, Anaissie EJ.

Oncol Nurs Forum. 2012 Sep;39(5):468-77. doi: 10.1188/12.ONF.468-477.

9.

Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry.

Steinbach WJ, Marr KA, Anaissie EJ, Azie N, Quan SP, Meier-Kriesche HU, Apewokin S, Horn DL.

J Infect. 2012 Nov;65(5):453-64. doi: 10.1016/j.jinf.2012.08.003. Epub 2012 Aug 13.

PMID:
22898389
10.

Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006.

Park BJ, Pappas PG, Wannemuehler KA, Alexander BD, Anaissie EJ, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt L, Ito JI, Kauffman CA, Lyon GM, Marr KA, Morrison VA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Wingard JR, Walsh TJ, Kontoyiannis DP.

Emerg Infect Dis. 2011 Oct;17(10):1855-64. doi: 10.3201/eid1710.110087.

11.

Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis.

Anaissie EJ, Coleman EA, Goodwin JA, Kennedy RL, Lockhart KD, Stewart CB, Coon SK, Bailey C, Barlogie B.

Cancer. 2012 Jan 15;118(2):549-57. doi: 10.1002/cncr.26302. Epub 2011 Jun 30.

12.

Fatigue, sleep, pain, mood, and performance status in patients with multiple myeloma.

Coleman EA, Goodwin JA, Coon SK, Richards K, Enderlin C, Kennedy R, Stewart CB, McNatt P, Lockhart K, Anaissie EJ, Barlogie B.

Cancer Nurs. 2011 May-Jun;34(3):219-27. doi: 10.1097/NCC.0b013e3181f9904d.

13.

Incidence and risk factors for lower alimentary tract mucositis after 1529 courses of chemotherapy in a homogenous population of oncology patients: clinical and research implications.

Krishna SG, Zhao W, Grazziutti ML, Sanathkumar N, Barlogie B, Anaissie EJ.

Cancer. 2011 Feb 1;117(3):648-55. doi: 10.1002/cncr.25633. Epub 2010 Sep 22.

14.

Factors associated with mortality in transplant patients with invasive aspergillosis.

Baddley JW, Andes DR, Marr KA, Kontoyiannis DP, Alexander BD, Kauffman CA, Oster RA, Anaissie EJ, Walsh TJ, Schuster MG, Wingard JR, Patterson TF, Ito JI, Williams OD, Chiller T, Pappas PG.

Clin Infect Dis. 2010 Jun 15;50(12):1559-67. doi: 10.1086/652768.

15.

Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.

Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, Ito J, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt LA, Kauffman CA, Knapp K, Lyon GM, Morrison VA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Wannemuehler KA, Wingard JR, Chiller TM, Pappas PG.

Clin Infect Dis. 2010 Apr 15;50(8):1091-100. doi: 10.1086/651263.

PMID:
20218877
16.

Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).

Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, Anaissie EJ, Brumble LM, Herwaldt L, Ito J, Kontoyiannis DP, Lyon GM, Marr KA, Morrison VA, Park BJ, Patterson TF, Perl TM, Oster RA, Schuster MG, Walker R, Walsh TJ, Wannemuehler KA, Chiller TM.

Clin Infect Dis. 2010 Apr 15;50(8):1101-11. doi: 10.1086/651262.

PMID:
20218876
18.

Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.

Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang CH, Webster KM.

Clin Infect Dis. 2009 Jun 15;48(12):1695-703. doi: 10.1086/599039.

PMID:
19441981
19.

Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation.

Sherman AC, Simonton S, Latif U, Plante TG, Anaissie EJ.

Biol Blood Marrow Transplant. 2009 Jan;15(1):12-20. doi: 10.1016/j.bbmt.2008.09.023.

20.

Diagnosis and therapy of fungal infection in patients with leukemia--new drugs and immunotherapy.

Anaissie EJ.

Best Pract Res Clin Haematol. 2008 Dec;21(4):683-90. doi: 10.1016/j.beha.2008.10.001. Review.

PMID:
19041608
21.

Prospective study of religious coping among patients undergoing autologous stem cell transplantation.

Sherman AC, Plante TG, Simonton S, Latif U, Anaissie EJ.

J Behav Med. 2009 Feb;32(1):118-28. doi: 10.1007/s10865-008-9179-y. Epub 2008 Oct 15.

PMID:
18855130
22.

Effects of exercise in combination with epoetin alfa during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for multiple myeloma.

Coleman EA, Coon SK, Kennedy RL, Lockhart KD, Stewart CB, Anaissie EJ, Barlogie B.

Oncol Nurs Forum. 2008 May;35(3):E53-61. doi: 10.1188/08.ONF.E53-E61.

23.

Destruction of isolates from the Pittsburgh Veterans Affairs Laboratory.

Snydman DR, Anaissie EJ, Sarosi GA.

Clin Infect Dis. 2008 Apr 1;46(7):1053-9. doi: 10.1086/528853.

PMID:
18444823
24.

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, van Burik JA, Wingard JR, Patterson TF; Infectious Diseases Society of America.

Clin Infect Dis. 2008 Feb 1;46(3):327-60. doi: 10.1086/525258. No abstract available.

PMID:
18177225
25.

A bad bug takes on a new role as a cause of ventilator-associated pneumonia.

Anaissie EJ.

Am J Respir Crit Care Med. 2008 Jan 1;177(1):1-2. No abstract available.

PMID:
18096711
26.

Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections.

Horn DL, Fishman JA, Steinbach WJ, Anaissie EJ, Marr KA, Olyaei AJ, Pfaller MA, Weiss MA, Webster KM, Neofytos D.

Diagn Microbiol Infect Dis. 2007 Dec;59(4):407-14. Epub 2007 Sep 20.

PMID:
17888614
27.
28.

Trial design for mold-active agents: time to break the mold--aspergillosis in neutropenic adults.

Anaissie EJ.

Clin Infect Dis. 2007 May 15;44(10):1298-306. Epub 2007 Apr 9. No abstract available.

PMID:
17443466
29.

Bisphosphonates and jaw osteonecrosis: the UAMS experience.

Clarke BM, Boyette J, Vural E, Suen JY, Anaissie EJ, Stack BC Jr.

Otolaryngol Head Neck Surg. 2007 Mar;136(3):396-400.

PMID:
17321866
30.

When a paradoxical increase in serum galactomannan antigen during caspofungin therapy is not paradoxical after all.

Miceli MH, Anaissie EJ.

Clin Infect Dis. 2007 Mar 1;44(5):757-60; author reply 760-1. No abstract available.

PMID:
17278073
31.

Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.

Anaissie EJ, Segal BH, Graybill JR, Arndt C, Perfect JR, Kleinberg M, Pappas P, Benjamin D, Rubin R, Aberg JA, Adderson EE, Adler-Shohet FC, Akan H, Akova M, Almyroudis NG, Alexander BD, Andes D, Arrieta A, Baddley JW, Barron MA, Belzberg H, Boucher HW, Boyce TG, Casadevall A, Chandrasekar PH, Cleary JD, Cordonnier C, Cornely OA, Cuenca-Estrella M, Daly JS, Daoura N, Denning DW, dePauw B, de Repentigny L, Dignani MC, Dismukes WE, Donnelly JP, Donowitz GR, Dupont B, Drusano G, Ellis M, Espinel-Ingroff A, Fishman JA, Fleming R, Forrest G, Ghannoum M, Goldman M, Grazziutti M, Greene JN, Greenberg RN, Gubbins PO, Hadley S, Herbrecht R, Hiemenz JW, Hope W, Hospenthal DR, Husain S, Ito JI, Jacobson RM, Johnson M, Keating MR, Kett DH, Knapp K, Kontoyiannis DP, Krcmery VC, Larsen R, Laverdiere M, Ljungman P, Lortholary O, Maertens J, Marriott D, Mattiuzzi G, McGinnis MR, Morris M, Nucci M, Odds FC, Pankey GA, Patterson T, Pfaller M, Razonable RR, Reboli AC, Rinaldi MG, Roberts GD, Rodriguez Tudela JL, Rotstein C, Ruhnke M, Schuster M, Shoham S, Sia IG, Siebel N, Silviera F, Singh N, Sobel J, Solomkin JS, Sorrell TC, Steinbach WJ, Temesgen Z, Tortorano A, Vartivarian S, VerWeij P, Viscoli C, Viviani MA, Walker RC, Wheat JL, Wiley J, Williamson P, Wingard JR, Yu VL, Zaoutis T.

Clin Infect Dis. 2006 Oct 15;43(8):1031-9. Epub 2006 Sep 13. No abstract available. Erratum in: Clin Infect Dis. 2007 Mar 15;44(6):894.

PMID:
16983616
32.

Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model.

Grazziutti ML, Dong L, Miceli MH, Krishna SG, Kiwan E, Syed N, Fassas A, van Rhee F, Klaus H, Barlogie B, Anaissie EJ.

Bone Marrow Transplant. 2006 Oct;38(7):501-6.

PMID:
16980998
33.

Pharmacokinetics and safety of oral posaconazole in neutropenic stem cell transplant recipients.

Gubbins PO, Krishna G, Sansone-Parsons A, Penzak SR, Dong L, Martinho M, Anaissie EJ.

Antimicrob Agents Chemother. 2006 Jun;50(6):1993-9.

34.

Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients.

Miceli MH, Dong L, Grazziutti ML, Fassas A, Thertulien R, Van Rhee F, Barlogie B, Anaissie EJ.

Bone Marrow Transplant. 2006 May;37(9):857-64.

PMID:
16532017
35.

Colonization and molecular epidemiology of coagulase-negative Staphylococcal bacteremia in cancer patients: a pilot study.

Costa SF, Barone AA, Miceli MH, van der Heijden IM, Soares RE, Levin AS, Anaissie EJ.

Am J Infect Control. 2006 Feb;34(1):36-40.

PMID:
16443091
36.

Recovery from neutropenia can be predicted by the immature reticulocyte fraction several days before neutrophil recovery in autologous stem cell transplant recipients.

Grazziutti ML, Dong L, Miceli MH, Cottler-Fox M, Krishna SG, Fassas A, van Rhee F, Barlogie BM, Anaissie EJ.

Bone Marrow Transplant. 2006 Feb;37(4):403-9.

PMID:
16400338
37.

International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia.

Ostrosky-Zeichner L, Kontoyiannis D, Raffalli J, Mullane KM, Vazquez J, Anaissie EJ, Lipton J, Jacobs P, van Rensburg JH, Rex JH, Lau W, Facklam D, Buell DN.

Eur J Clin Microbiol Infect Dis. 2005 Oct;24(10):654-61. Erratum in: Eur J Clin Microbiol Infect Dis. 2006 Jan;25(1):69.

PMID:
16261306
38.

The clinical spectrum of stenotrophomonas (xanthomonas) maltophilia respiratory infection.

Vartivarian SE, Anaissie EJ, Kiwan EN, Papadakis KA.

Semin Respir Crit Care Med. 2000;21(4):349-55.

PMID:
16088746
39.

Are antimicrobial-impregnated catheters effective? Replace the water and grab your washcloth, because we have a baby to wash.

McConnell SA, Gubbins PO, Anaissie EJ.

Clin Infect Dis. 2004 Dec 15;39(12):1829-33. Epub 2004 Nov 19.

PMID:
15578407
40.

Genetic diversity of human pathogenic members of the Fusarium oxysporum complex inferred from multilocus DNA sequence data and amplified fragment length polymorphism analyses: evidence for the recent dispersion of a geographically widespread clonal lineage and nosocomial origin.

O'Donnell K, Sutton DA, Rinaldi MG, Magnon KC, Cox PA, Revankar SG, Sanche S, Geiser DM, Juba JH, van Burik JA, Padhye A, Anaissie EJ, Francesconi A, Walsh TJ, Robinson JS.

J Clin Microbiol. 2004 Nov;42(11):5109-20.

41.

Diagnosis of infection of implantable central venous catheters by [18F]fluorodeoxyglucose positron emission tomography.

Miceli MH, Jones Jackson LB, Walker RC, Talamo G, Barlogie B, Anaissie EJ.

Nucl Med Commun. 2004 Aug;25(8):813-8.

PMID:
15266176
42.

A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy.

Giles FJ, Rodriguez R, Weisdorf D, Wingard JR, Martin PJ, Fleming TR, Goldberg SL, Anaissie EJ, Bolwell BJ, Chao NJ, Shea TC, Brunvand MM, Vaughan W, Petersen F, Schubert M, Lazarus HM, Maziarz RT, Silverman M, Beveridge RA, Redman R, Pulliam JG, Devitt-Risse P, Fuchs HJ, Hurd DD.

Leuk Res. 2004 Jun;28(6):559-65.

PMID:
15120931
43.

Mucosa or skin as source of coagulase-negative staphylococcal bacteraemia?

Costa SF, Miceli MH, Anaissie EJ.

Lancet Infect Dis. 2004 May;4(5):278-86. Review. Erratum in: Lancet Infect Dis. 2004 Aug;4(8):533.

PMID:
15120344
44.

Bradycardia during therapy for multiple myeloma with thalidomide.

Fahdi IE, Gaddam V, Saucedo JF, Kishan CV, Vyas K, Deneke MG, Razek H, Thorn B, Bissett JK, Anaissie EJ, Barlogie B, Mehta JL.

Am J Cardiol. 2004 Apr 15;93(8):1052-5. Erratum in: Am J Cardiol. 2004 Dec 1;94(11):1480. Anaisse, Elias [corrected to Anaissie, Elias J].

PMID:
15081457
45.

Lipid formulations of amphotericin B preserve and stabilize renal function in HSCT recipients.

Miller CB, Waller EK, Klingemann HG, Dignani MC, Anaissie EJ, Cagnoni PJ, McSweeney P, Fleck PR, Fruchtman SM, McGuirk J, Chao NJ.

Bone Marrow Transplant. 2004 Mar;33(5):543-8.

PMID:
14730342
46.

Infections in patients with hematological cancer: recent developments.

O'Brien SN, Blijlevens NM, Mahfouz TH, Anaissie EJ.

Hematology Am Soc Hematol Educ Program. 2003:438-72. Review.

PMID:
14633794
47.

The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management.

Anaissie EJ, Mahfouz TH, Aslan T, Pouli A, Desikan R, Fassas A, Barlogie B.

Blood. 2004 Mar 1;103(5):1611-7. Epub 2003 Oct 2.

PMID:
14525792
48.

A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial).

Giles FJ, Miller CB, Hurd DD, Wingard JR, Fleming TR, Sonis ST, Bradford WZ, Pulliam JG, Anaissie EJ, Beveridge RA, Brunvand MM, Martin PJ; PROMPT-CT Trial Investigators.

Leuk Lymphoma. 2003 Jul;44(7):1165-72.

PMID:
12916869
49.

Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection.

Nucci M, Anaissie EJ, Queiroz-Telles F, Martins CA, Trabasso P, Solza C, Mangini C, Simões BP, Colombo AL, Vaz J, Levy CE, Costa S, Moreira VA, Oliveira JS, Paraguay N, Duboc G, Voltarelli JC, Maiolino A, Pasquini R, Souza CA.

Cancer. 2003 Jul 15;98(2):315-9.

50.

Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection?

McConnell SA, Gubbins PO, Anaissie EJ.

Clin Infect Dis. 2003 Jul 1;37(1):65-72. Epub 2003 Jun 24. Review.

PMID:
12830410

Supplemental Content

Loading ...
Support Center